Clinical Trial Update: Investigation of Novel Surgical Imaging for Tumor Excision [Phase 3]

View source ↗

Summary

Phase 3 trial results for a novel surgical imaging agent used during tumor excision in breast cancer have been completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Lumicell, Inc. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2023-08-24